List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Eastern Equine Encephalitis - Overview
Eastern Equine Encephalitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Eastern Equine Encephalitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Eastern Equine Encephalitis - Companies Involved in Therapeutics Development
Bavarian Nordic A/S
Profectus BioSciences Inc
Ridgeback Biotherapeutics LP
Eastern Equine Encephalitis - Drug Profiles
EIDD-2801 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
encephalitis (trivalent,virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
equine encephalitis (trivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
equine encephalitis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Eastern Equine Encephalitis and Venezuelan Equine Encephalitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit Myd88 for Infectious Diseases, Inflammation, Septic Shock and Toxic Shock - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TSI-GSD-104 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Eastern Equine Encephalitis - Dormant Projects
Eastern Equine Encephalitis - Product Development Milestones
Featured News & Press Releases
Apr 18, 2019: UofL researcher developing drug to treat emerging encephalitis viruses
Jan 24, 2019: Bavarian Nordic advances development of equine encephalitis virus vaccine
Dec 09, 2015: Profectus BioSciences Receives $4.6 Million DOD Grant to Develop Vaccine for Western, Eastern, and Venezuelan Equine Encephalitis Viruses
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Eastern Equine Encephalitis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Eastern Equine Encephalitis - Pipeline by Bavarian Nordic A/S, H1 2020
Eastern Equine Encephalitis - Pipeline by Profectus BioSciences Inc, H1 2020
Eastern Equine Encephalitis - Pipeline by Ridgeback Biotherapeutics LP, H1 2020
Eastern Equine Encephalitis - Dormant Projects, H1 2020

List of Figures
Number of Products under Development for Eastern Equine Encephalitis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020

Companies Mentioned
• Bavarian Nordic A/S
• Profectus BioSciences Inc
• Ridgeback Biotherapeutics LP